LBA9 TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety analysis

P. Grivas, T.B. Powles, Christof Vulsteke, M. Gross Goupil, S.H. Park, A. Necchi, M. De Santis, I. Duran, Rafael Morales‐Barrera, Jun Guo, C.N. Sternberg, J. Bellmunt, Peter J. Goebell, Francis Boateng, M. Sierecki, Lin Wang, Camelia S. Sima, Jana Waldes, S.T. Tagawa, Y. Loriot